AI Summary A lipid panel is a blood test that reports total cholesterol, LDL, HDL, and triglycerides. It does not measure liver damage. Doctors order it to check metabolic and heart risk in fatty liver disease, diabetes, and after a liver transplant. Ask your doctor whether you need to fast. Results are read with liver tests, imaging, and your history. Statins are safe for high blood fats in fatty liver disease but should be avoided in decompensated cirrhosis.
Source: www.liverdirectory.com
Medically Reviewed.
A lipid panel is a blood test that reports your total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. It does not measure liver damage. Doctors use it to look at metabolic and heart risk, which often travel with fatty liver disease.
Abnormal blood fats are one of the risk factors doctors look for when they diagnose metabolic dysfunction–associated steatotic liver disease (MASLD). Your care team reads the panel together with liver function tests, imaging, and your medical history.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT THE LIPID PANEL
A lipid panel, also called a lipid profile or cholesterol test, is a blood test that measures the fats (lipids) in your blood. A standard report lists four results:
The liver plays a central role in how your body handles these fats. That is why abnormal lipid results and liver disease often appear together, especially in fatty liver disease.
A lipid panel is not a liver function test. It does not show whether liver cells are injured or scarred. Liver enzymes such as ALT and AST, imaging, and fibrosis scores answer those questions.
The panel matters for a second reason. Cardiovascular disease is the most common cause of death in people with non-alcoholic fatty liver disease (NAFLD). Checking blood fats helps your care team look after your heart as well as your liver.
WHEN IT IS ORDERED
A lipid panel answers a metabolic and heart-risk question. It is one piece of a liver work-up, not a stand-alone liver test.
Doctors diagnose MASLD by combining imaging with lab tests, including liver enzymes, fasting glucose, HbA1c, and lipid panels. They also look for at least one cardiometabolic risk factor. Dyslipidemia, such as elevated triglycerides or low HDL cholesterol, is one of them. Others include obesity, insulin resistance or type 2 diabetes, and high blood pressure.
MASLD raises the risk of heart and blood vessel disease, which is its leading cause of death. Cardiovascular disease accounts for about 40% of deaths in people with MASLD. Because the two conditions share risk factors, people with MASLD should be screened for heart conditions. A lipid panel is a routine part of that screening.
People with type 2 diabetes should have cholesterol and triglyceride levels checked once a year, along with A1C, blood pressure, and kidney tests.
Dyslipidemia, meaning high cholesterol and triglycerides, raises cardiovascular risk after a liver transplant. Some immunosuppressants can promote it. Early identification and treatment are part of managing metabolic syndrome in transplant recipients.
THE BLOOD DRAW
A lipid panel uses a standard blood draw. Most people need no special equipment or recovery time.
Your doctor will receive the results and contact you.
Download Free Liver Test Patient GuideINTERPRETATION
Lab reports list each result in mg/dL (milligrams per deciliter) and flag values outside the lab's range. The cutoffs below are example definitions. Your care team may set different goals for you.
The total amount of cholesterol carried in your blood.
200 mg/dL or lower
Not flagged as high by this definition.
Not flagged as high.
Above 200 mg/dL counts as high by this definition. Your doctor looks at this together with LDL, HDL, and your other risks.
Often called "bad" cholesterol. Doctors track it to judge heart and blood vessel risk.
130 mg/dL or lower (100 mg/dL or lower with diabetes)
Not flagged as high by this definition.
Not flagged as high.
Above 130 mg/dL (above 100 mg/dL if you have diabetes) counts as high by this definition.
Often called "good" cholesterol. It is reviewed alongside triglycerides.
Varies by lab. See your report.
Low HDL cholesterol is a dyslipidemia pattern and a cardiometabolic risk factor for MASLD.
Within your lab's range, your result is not flagged.
Your report will flag values outside the lab's range. Ask your provider what a flagged result means for you.
A type of fat in the blood. Levels often rise with fatty liver and diabetes.
150 mg/dL or lower
Not flagged as high by this definition.
Not flagged as high.
Above 150 mg/dL counts as hypertriglyceridemia by this definition. Elevated triglycerides are a MASLD risk factor.
A single result is a snapshot. Your doctor weighs your lipid panel against your age, diabetes status, blood pressure, liver tests, and any medicines you take. Do not change or stop a medicine because of one result.
HOW IT COMPARES
Each metabolic blood test answers a different question. Doctors often order them at the same visit.
The lipid panel measures blood fats. Fasting glucose measures blood sugar. Diabetes is diagnosed when fasting glucose is 126 mg/dL or higher on two occasions. A lipid panel cannot diagnose diabetes.
Liver function tests look at enzymes such as ALT and AST, which can show liver stress. A lipid panel shows metabolic and heart risk. The two work as a pair when fatty liver is suspected.
Some noninvasive scores for fatty liver use the lipid profile as one input, along with body mass index, blood sugar, and liver enzymes. The lipid panel itself does not produce a fatty liver score.
CLINICAL CONTEXT
MASLD is a risk factor for atherosclerotic cardiovascular disease, and that disease is the main cause of death in people with MASLD. People with MASLD also face a 36% higher risk of heart failure. For this reason, abnormal lipid results in fatty liver disease are treated as a heart-health issue too.
Statins are safe for treating dyslipidemia and lowering cardiovascular risk in people with NAFLD and NASH, because they do not increase the risk of serious liver injury. They should be avoided in decompensated cirrhosis. In compensated (Child-Pugh A) cirrhosis, moderate doses have not caused a major rise in muscle toxicity, and lower doses are recommended in decompensated disease. Your care team chooses the medicine and dose for you.
Resmetirom (Rezdiffra), a medicine for MASH, lowers LDL cholesterol by 13% to 16%, along with apolipoprotein B and triglycerides. It is meant to be added to standard cholesterol-lowering care, not to replace it. It also raises the levels of several statins, so your doctor may cap the statin dose.
A balanced, liver-friendly diet supports your liver, helps manage weight and blood sugar, and lowers the risk of other health problems during long-term follow-up.
Explore Liver DietThe Amsety Bar is a liver-friendly snack or meal replacement that can make it easier to eat well on busy days.
Shop Amsety Bars
COMMON QUESTIONS
Not always. Ask your doctor, because fasting may be needed if other tests are drawn at the same visit. Your care team will tell you what to do before your blood draw.
No. A lipid panel measures blood fats, not liver damage. Liver function tests, imaging, and fibrosis scores check the liver itself. Doctors use the lipid panel to assess metabolic and heart risk, which are closely tied to fatty liver disease.
Yes. Abnormal blood fats often appear with fatty liver disease. Elevated triglycerides and low HDL cholesterol are cardiometabolic risk factors. With fat in the liver, at least one such factor establishes MASLD.
Usually yes. Statins are safe for treating dyslipidemia in people with NAFLD and NASH, and they do not increase the risk of serious liver injury. They should be avoided in decompensated cirrhosis. Your doctor decides based on your liver stage.
It depends on your health. People with type 2 diabetes should have cholesterol and triglyceride levels checked once a year. Ask your doctor how often you need a panel if you have fatty liver disease or a liver transplant.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
